The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading lower by 17 points at 24,853 indicating that the domestic benchmark indices are likely to make a lacklustre start on Monday.
Earlier on Friday, 30 May, Domestic benchmark indices S&P BSE Sensex slumped by 182.01 points or 0.22% and settled at 81,451.01 while the Nifty50 traded 0.33% lower by 82.9 points, settling at 24,750.7.
Here are some stocks that are likely to remain in focus on 2 June.
Quarterly Results Today: Manoj Jewellers, N2N Technologies, Vasudhagama Enterprises, Panorama Studios International, and Retro Green Revolution are some of the prominent companies set to announce their quarterly earnings for January-March.
Alembic Pharma: The USFDA conducted an unannounced routine cGMP inspection at Alembic Pharmaceuticals’ API-I and API-II units in Panelav from 26 May to 31 May 2025 and issued a Form 483 with four observations. The company clarified that none of the observations pertain to data integrity.
IRCON International: IRCON International has secured an EPC contract worth Rs 1,068.34 crore from East Central Railway. The project involves building a new broad gauge rail bridge across the river Ganga between Bikramshila and Katareah stations, including the sub-structure for a double-line track and the superstructure for a single-line track.
Cipla: The USFDA completed a cGMP inspection at Cipla’s Bommasandra manufacturing facility in Bengaluru from 26 May to 30 May 2025 and issued one observation in Form 483. Meanwhile, Cipla’s Board has approved the appointment of Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer and Senior Management Personnel, effective 1 July.
Godrej Properties: Godrej Properties has acquired a 14-acre land parcel in Kharadi-Wagholi, Pune. The company aims to develop a premium residential project on the site with a developable area of 3.7 million sq. ft., projecting a revenue potential of Rs 4,200 crore.
Adani Energy Solutions: The company has bagged an inter-state transmission project worth Rs 1,660 crore in Maharashtra, pushing its transmission order book to Rs 61,600 crore. Additionally, the company’s Board has approved a fundraising of up to Rs 4,300 crore through Qualified Institutional Placement (QIP) or other methods.
Coal India: Coal India has submitted draft papers with SEBI, NSE, and BSE for the IPO of its subsidiary, Bharat Coking Coal. The IPO will involve an offer for the sale of up to 46.57 crore shares by the parent company.
Zydus Lifesciences: The company has announced securing tentative approval from the USFDA for its Rifaximin tablets, used to treat irritable bowel syndrome with diarrhoea (IBS-D) in adults. According to IQVIA MAT March 2025 data, annual sales of Rifaximin tablets in the US stood at $2,672.9 million.
Dr Reddy’s Lab: Dr Reddy’s Laboratories has received a tax demand notice of Rs 2,395.81 crore from the Assistant Commissioner of Income Tax, Hyderabad, for the Assessment Year 2020–21.
The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!
